FDA
-
-
-
-
-
-
-
Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
-
-
-
-
-
-
-
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019
-
-
-
-
-
-
-
Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019
-
-
-
-
-
-
-
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

